{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:23:54Z","timestamp":1794029034265,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":207,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008276","name":"College of Medicine, University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.101078","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:17:32Z","timestamp":1785539852000},"page":"101078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age, Rather Than Social Vulnerability, Is Associated With Disparities in Prescription Patterns in Inflammatory Bowel Disease: An Epic Cosmos Study"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6059-5902","authenticated-orcid":false,"given":"Hannah","family":"Zuercher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Potlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousumi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shay S.","family":"Bidani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianze","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naueen A.","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gastha.2026.101078_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cgh.2024.06.050","article-title":"Modern advanced therapies for inflammatory bowel diseases: practical considerations and positioning","volume":"23","author":"Fudman","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101078_bib2","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.3390\/jcm14176119","article-title":"Emerging therapies in inflammatory bowel disease: a comprehensive review","volume":"14","author":"Appiah","year":"2025","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.gastha.2026.101078_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","article-title":"Understanding the therapeutic toolkit for inflammatory bowel disease","volume":"22","author":"Vieujean","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gastha.2026.101078_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/17474124.2025.2469832","article-title":"Progressing advanced therapies for inflammatory bowel disease: current status including dual biologic therapy and discontinuation of biologics","volume":"19","author":"Yashima","year":"2025","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.gastha.2026.101078_bib5","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.cgh.2022.03.011","article-title":"The impact of the social determinants of health on disparities in inflammatory bowel disease","volume":"20","author":"Anyane-Yeboa","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101078_bib6","first-page":"165","article-title":"Medical and social determinants of health as predictors of adverse outcomes in patients with inflammatory bowel disease","volume":"36","author":"Shah","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"12","key":"10.1016\/j.gastha.2026.101078_bib7","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.14309\/ajg.0000000000000794","article-title":"Social determinants of outcomes in inflammatory bowel disease","volume":"115","author":"Bernstein","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"1\u20132","key":"10.1016\/j.gastha.2026.101078_bib8","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1017\/dmp.2023.29","article-title":"Measuring historic and longitudinal social vulnerability in disaster-prone communities: a modification to the centers for disease control and prevention social vulnerability index (CDC-SVI)","volume":"17","author":"Adepoju","year":"2023","journal-title":"Disaster Med Public Health Prep"},{"key":"10.1016\/j.gastha.2026.101078_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajo.2024.02.022","article-title":"Socioeconomic disparities in glaucoma severity at initial diagnosis: a nationwide electronic health record cohort analysis","volume":"263","author":"Swaminathan","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101078_bib10","article-title":"Increased prevalence of psychiatric conditions in panniculectomy patients with prior bariatric surgery: a nationwide epic cosmos study","volume":"17","author":"Vance","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.gastha.2026.101078_bib11","article-title":"Association between different modalities of opioid use disorder-related care delivery and opioid use disorder-related patient outcomes: a retrospective cohort study","volume":"21","author":"Bin Noor","year":"2025","journal-title":"Addict Behav Rep"},{"issue":"1","key":"10.1016\/j.gastha.2026.101078_bib12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-053498","article-title":"Birth hospital length of stay and rehospitalization during COVID-19","volume":"149","author":"Handley","year":"2022","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.gastha.2026.101078_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41575-022-00738-z","article-title":"Improving IBD outcomes in the era of many treatment options","volume":"20","author":"Kobayashi","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101078_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.gastha.2026.101078_bib16","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cgh.2023.12.023","article-title":"Comparative efficacy of advanced therapies for achieving endoscopic outcomes in Crohn's disease: a systematic review and network meta-analysis","volume":"22","author":"Vuyyuru","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gastha.2026.101078_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ecco-jcc\/jjad203","article-title":"Biologic therapy for inflammatory bowel disease: real-world comparative effectiveness and impact of drug sequencing in 13 222 patients within the UK IBD BioResource","volume":"18","author":"Kapizioni","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.gastha.2026.101078_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/ecco-jcc\/jjz150","article-title":"Environmental, nutritional, and socioeconomic determinants of IBD incidence: a global ecological study","volume":"14","author":"Piovani","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.gastha.2026.101078_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ibd.22986","article-title":"Systematic review: the role of race and socioeconomic factors on IBD healthcare delivery and effectiveness","volume":"19","author":"Sewell","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.gastha.2026.101078_bib20","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gastha.2026.101078_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15585\/mmwr.mm6706a4","article-title":"Health-risk behaviors and chronic conditions among adults with inflammatory bowel disease \u2014 United States, 2015 and 2016","volume":"67","author":"Xu","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.gastha.2026.101078_bib22","first-page":"619","article-title":"Prevalence of inflammatory bowel disease in pediatric and adult populations: recent estimates from large national databases in the United States, 2007-2016","volume":"26","author":"Ye","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"24","key":"10.1016\/j.gastha.2026.101078_bib23","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.3390\/jcm13247534","article-title":"Sex-based disparities in treatment and healthcare utilization in patients with ulcerative colitis: a systematic review and meta-analysis","volume":"13","author":"Shah","year":"2024","journal-title":"J Clin Med"},{"issue":"10S","key":"10.1016\/j.gastha.2026.101078_bib24","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.14309\/01.ajg.0000860820.62357.d2","article-title":"S1045 racial disparities in utilization of medications in inflammatory bowel disease patients","volume":"117","author":"Alchirazi","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.gastha.2026.101078_bib25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/ibd\/izab219","article-title":"Racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"28","author":"Barnes","year":"2022","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.gastha.2026.101078_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-022-02560-y","article-title":"Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies","volume":"22","author":"Cai","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"10.1016\/j.gastha.2026.101078_bib27","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1097\/MIB.0000000000000835","article-title":"Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences","volume":"22","author":"Afzali","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.gastha.2026.101078_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/ibd\/izae219","article-title":"Healthcare utilization and geographic distribution of advanced therapy in minority race and ethnic groups with inflammatory bowel disease","volume":"31","author":"Hussain","year":"2025","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.gastha.2026.101078_bib29","doi-asserted-by":"crossref","first-page":"S-321","DOI":"10.1016\/S0016-5085(24)01219-8","article-title":"Sa1018 publicly insured patients with IBD, including those with severe disease, are more likely to receive steroids and less likely to be treated with advanced therapies than privately insured patients","volume":"166","author":"Potlach","year":"2024","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gastha.2026.101078_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.gastro.2020.08.064","article-title":"Effects of race and ethnicity on diagnosis and management of inflammatory bowel diseases","volume":"160","author":"Barnes","year":"2021","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.gastha.2026.101078_bib31","doi-asserted-by":"crossref","first-page":"A138","DOI":"10.1136\/gut.2011.239301.292","article-title":"Racial differences in use of biologics for crohn's disease in a medicaid population","volume":"60","author":"Flasar","year":"2011","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.gastha.2026.101078_bib32","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/ajg.2013.192","article-title":"The effects of race and socioeconomic status on immunomodulator and anti-tumor necrosis factor use among ambulatory patients with inflammatory bowel disease in the United States","volume":"108","author":"Lin","year":"2013","journal-title":"Am J Gastroenterol"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:25:31Z","timestamp":1794025531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326001998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326001998"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101078","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age, Rather Than Social Vulnerability, Is Associated With Disparities in Prescription Patterns in Inflammatory Bowel Disease: An Epic Cosmos Study","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101078"}}